PGHH · Procter & Gamble Hygiene and Health Care Ltd · Personal & Household Prods.
PGHH · Procter & Gamble Hygiene and Health Care Ltd · Personal & Household Prods.
As of 05 Nov close
52-week range
47.9% below 52-week high
52-week range: as of 05 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 16 Oct 2026
Revenue (latest Q)
₹890 Cr
Revenue YoY
PAT YoY
-34.3%
Operating margin
Revenue, last 5 quarters
Source: Yahoo Finance, as of 30 Jun 2026
P/E (TTM)
P/B
29.8
P/S (TTM)
Not available from data source
Sector P/E
Not available from data source
Dividend yield
+3.3%
Source: Yahoo Finance, as of 29 Oct 2026
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| PGHH (this stock) | 28.4 | 29.8 | +18.7% | +113.7% | 0 | +3.3% |
| Hindustan Unilever * | 47.5 | 9.5 | +22.5% | +30.7% | 0.03 | +2.1% |
| Marico * | 57.4 | 62.3 | +13.2% | +44.9% | 0.13 | +0.5% |
| Godrej Consumer Products * | 54 | 36.4 | +12.2% | +15.1% | 0.35 | +2.3% |
* Net margin, ROE, D/E and dividend yield for these companies come from RedixFi fundamentals; the data vendor had no values for them.
Promoter
stable
FII
stable
MF
8.00% (-0.65pp)
falling 2q
Insider trades
| Date | Insider | Type | Qty | Value |
|---|---|---|---|---|
| 19 Jun 2026 | Temple Trees Impex and Investment Private Limited | SELL | 6,19,683 | ₹557 Cr |
| 19 Jun 2026 | Procter & Gamble Home Products Private Limited | BUY | 6,19,683 | ₹557 Cr |
Bulk/block deals
No bulk/block deals in the last 12 months.
News timeline
No related news.
Concalls & investor presentations
AI-generatedKey takeaway: Procter & Gamble Hygiene and Health Care Limited held an earnings call on June 16, 2026, where management discussed the company's financial performance for the fiscal year ending March 31, 2026. The company reported sales of approximately 4300 crores, remaining flat compared to the previous year, while Profit After Tax (PAT) increased by 19% to about 850 crores. Management highlighted a focus on consumer-centric innovation and strengthening go-to-market capabilities. They acknowledged challenges such as media fragmentation, inflation, and evolving retail landscapes. The call emphasized the importance of an integrated growth strategy, which includes delivering superior products, enhancing productivity, and fostering constructive disruption. Management also noted the success of specific product lines, including Whisper Period Panties and Vicks Cough Syrup, and discussed ongoing efforts to adapt to changing consumer preferences and competitive pressures. The session concluded with a Q&A segment addressing various industry trends and company strategies.
Management reported mixed results, highlighting both challenges and successes in their strategies.
Sourced from an exchange-filed transcript, dated 16 Jun 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Procter & Gamble Hygiene and Health Care Limited provided an update on its analysts/institutional investors meeting held on June 16, 2026. The presentation included fiscal results for 2025-26, reporting flat sales and a 19% increase in profit after tax (PAT). The company noted a change in its financial year, which now runs from April 1 to March 31, affecting comparability with previous results. Management discussed external landscape changes, including inflation and retail transformation, and outlined an integrated growth strategy focused on consumer superiority and portfolio performance. The presentation highlighted productivity savings of INR 86 crores for FY 25/26 and emphasized long-term trends showing a 6% CAGR in net sales and an 8% CAGR in PAT over the past decade. The document concluded with insights on evolving consumption trends and the company's commitment to creating shareholder value.
The presentation provided a balanced overview of results and strategic initiatives without strong emphasis on positive or negative aspects.
Sourced from an exchange-filed presentation, dated 16 Jun 2026. Summary is RedixFi-generated and distinct from investment advice.
AI Summary of Annual Report
AI-generatedThe report highlights the company's continued focus on integrated growth strategies, emphasizing consumer-centric innovation in feminine care and healthcare products. It outlines efforts to enhance product offerings, such as the Whisper Period Panty portfolio, to meet evolving consumer needs. The company also underscores its commitment to sustainability, including waste reduction and environmental compliance, and highlights its corporate social responsibility initiatives like P&G Shiksha. Management expressed confidence in executing its strategy to drive balanced growth and value creation across stakeholders.
- Commitment to integrated growth strategy with consumer-centric innovation in feminine care and healthcare portfolios.
- Enhancement of product offerings like Whisper Period Panty to address evolving consumer needs for comfort and protection.
- Sustainability initiatives including zero manufacturing waste-to-landfill and efforts to reduce plastic packaging waste.
Key takeaway: The company is focused on driving balanced growth through consumer innovation and sustainability, while maintaining strong corporate governance and social responsibility practices.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
Default / Covenant Breach (1 item)
Items of these kinds are disclosed in the filings. This is a count of disclosed items. It is not a finding about the company and its cause has not been independently established.
Default / Covenant Breach
1 occurrenceEarlier (1-3 years ago)
The company has outstanding tax, duty, and statutory dues in arrears for over six months as of March 31, 2025, including amounts totaling ₹44,240 lakhs under Goods and Services Tax and ₹2,132 lakhs under GST Intelligence.
Routine disclosures
Contingent Liability
2 occurrencesRecent (last 12 months)
The company has provisions and contingent liabilities related to taxation matters, as noted in notes 3.2, 26, and 35 of the Ind-AS financial statements.
Earlier (1-3 years ago)
The company has ongoing disputes with Tax Authorities on various matters pending before appellate authorities, which are disclosed as contingent liabilities based on the probability of success in the appellate matters.
Related-Party Transaction
1 occurrenceRecent (last 12 months)
The company entered into a material related party transaction with Procter & Gamble Home Products Private Limited for purchase of goods worth 661.26 Crores during the Financial Year 2025-26. The transaction was approved by shareholders via an Ordinary Resolution at the Annual General Meeting held on November 24, 2023, with promoter shareholders abstaining from voting.
Promoter Share Pledge
1 occurrenceRecent (last 12 months)
0.86% of promoter holding pledged (quarter 2026-Q3 as of 2026-07-18).